LRAD Corp. named its interim CFO, Dennis Klahn, to the post permanently.
Marijuana will soon be legal across California. However, here in San Diego, there’s still one big cartel left vying for control over the local industry: the United Medical Marijuana Coalition.
DESIGN: Customization Skills Set It Apart; B2B Market Potential Big
Lighting typically represents less than 1 percent of a building’s cost, while it casts a much bigger impact on ambience.
Northrop Grumman Corp. stands to gain an even higher profile in San Diego if the Virginia-based company completes its $9.2 billion acquisition of Orbital ATK.
Having proven that clean energy can be a strong economic driver, San Diego has committed to achieving 100 percent renewable energy from sources like solar, wind, and geothermal energy by 2035. We believe the rest of the state can and should follow San Diego’s lead.
A 2.3 percent excise tax on all medical devices sold in the U.S. could resume in 2018, sparking a renewed push among San Diego’s medtech hub to scrap the measure.
San Diego drugmaker Halozyme Inc. has bagged two separate deals to partner its technology with Big Pharma drugs, adding $135 million to the company’s coffers and nearly $2 billion in potential future income.
BREWING: From Tanks to T-Shirts, Sector Is Thriving
Without brewing a drop of beer themselves, several San Diego County companies — such as dispensing-systems provider TapCraft and temperature-gauging tech maker Reotemp Instruments Corp. — are enjoying the spillover benefits of the region’s still-burgeoning craft brewing industry.
JUICE: Investment Boosts Co.’s Capacity, But Doesn’t Change Its Philosophy
Suja Life LLC’s first commercial juice press, a blue machine about the size of a minifridge, still stands on the floor of its Oceanside production facility. But nearby is the real powerhouse: a German-made Flottweg belt press with the ability to squeeze nearly all of the juice from the produce it mashes.
La Jolla-based Sophiris Bio Inc. has borrowed $7 million from Silicon Valley Bank to help finance late stage clinical trials and to extend the company’s cash runway through 2019.
San Diego-based RF Industries Ltd. reported net income of $192,000 or 2 cents per share on net sales of $7.8 million in its third quarter, which ended July 31.
Akcea Therapeutics, a spinout and subsidiary of Carlsbad drugmaker Ionis Pharmaceuticals, has asked for the green light from regulators to sell one of its drugs in Canada.
Lytx said it plans to move manufacturing for its DriveCam video event recorders from mainland China to Indiana.
Local biotech Zavante Therapeutics is teaming up with the National Institutes of Health to see if its antibiotic will fight nasty infections acquired in hospitals.
Public drugmaker Pfenex Inc. is losing two of its top executives: Chief Financial Officer Paul Wagner and Chief Manufacturing Officer Steve Sandoval.